-
Deconstructing Peripheral Neuropathy and Chemo Brain
Researchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
by Marci A. Landsmann
-
AACR Annual Meeting 2023
Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.
-
Building Bridges
AACR Scientist↔Survivor Program celebrates 25 years of sparking conversations between cancer patients and researchers.
by Thomas Celona
-
The State of Cancer Care and Pregnancy
An expert panel at the AACR Annual Meeting discussed the difficult choices faced when cancer is diagnosed during a pregnancy and how recent laws have brought additional challenges.
by Eric Fitzsimmons
-
Decoding Disparities in Colorectal Cancer
People of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment options.
by Marci A. Landsmann
-
Nudging Our Way to Better Cancer Care
Researchers use insights from behavioral economics to encourage taking recommended actions in health care.
by Kevin McLaughlin
-
Post-surgery Option for Liver Cancer
New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
by Thomas Celona
-
Chronic Stress and Cancer
Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.
by Thomas Celona
-
Forward Look
Progress in Personalized Cancer VaccinesStudy finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
by Thomas Celona
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore